Physician Assessment of the Clinical Utility of a Patient-Specific 3D Electro-Anatomical Heart Model in VT Ablation

Stopped early

Conditions studied: Ischemic Monomorphic Ventricular Tachycardia

In brief

ACE-VT is a clinical pilot study designed to evaluate the ability of the CardioSolv Software System to generate an output for the physician to review in a timely fashion, consistent with the standard of care VT ablation workflow. This study will assess the acute effectiveness of using the CardioSolv Software System output as additional supporting information during ablation.

Key facts

Study ID

NCT04841382

Run by

CardioSolv Ablation Technologies

People needed

1

Starts

2021-06-01

Expected to finish

2022-10-06

Last updated by the study team

2022-10-19

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant meets standard criteria for VT ablation and is scheduled for VT ablation by their cardiologist or electrophysiologist
• 18 to 85 years of age
• VT and ischemic cardiomyopathy
• A pre-procedure MRI with LGE is available (performed within 1 year of procedure, unless an MI has occurred since MRI) with adequate image for analysis
• Participant is able and willing to provide written informed consent

You may not qualify if…

• Contradiction to MRI (except those with MRI compatible pacemaker/ICD/CRT devices implanted or site has approved procedure for MRI of non-compatible devices).
• Participant implanted with an LVAD.
• Enrolled in another non-imaging intervention assignment study that could confound the results of this study.

Where it is running

• Upenn — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.